$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

REVIEW OF CLINICAL EXPERIENCE WITH ATOSIBAN AND THE TRACTOCILE EFFICACY ASSESSMENT SURVEY IN EUROPE (TREASURE) STUDY PROTOCOL

International journal of clinical practice, v.57 no.2, 2003년, pp.121 - 127  

Husslein, P (Department of Obstetrics and Gynaecology University Medical School Vienna Austria) ,  Quartarolo, JP (Medical Department Ferring Scandinavia Copenhagen Denmark)

Abstract AI-Helper 아이콘AI-Helper

SUMMARYA phase IV multinational, multicentre study has been designed - the Tractocile Efficacy Assessment Survey in Europe (TREASURE). The aim is to assess atosiban in the clinical setting, which is associated with fewer restrictions than in phase III trials. Atosiban is to be compared with ‘u...

참고문헌 (32)

  1. Res Clin Forums Scheider H. 59 16 1994 Pharmacological intervention in preterm labour 

  2. Keirse, Marc J.N.C.. New perspectives for the effective treatment of preterm labor. American journal of obstetrics and gynecology, vol.173, no.2, 618-628.

  3. Finnström, O, Olausson, P Otterblad, Sedin, G, Serenius, F, Svenningsen, N, Thiringer, K, Tunell, R, Wennergren, M, Wesström, G. The Swedish national prospective study on extremely low birthweight (ELBW) infants. Incidence, mortality, morbidity and survival in relation to level of care. Acta pædiatrica = Acta Paediatrica, vol.86, no.5, 503-511.

  4. CROWLEY, PATRICIA, CHALMERS, IAIN, KE1RSE, MARC J. N. C.. The effects of corticosteroid administration before preterm delivery: an overview of the evidence from controlled trials. British journal of obstetrics and gynaecology, vol.97, no.1, 11-25.

  5. Effect of corticosteroids for fetal maturation on perinatal outcomes: consensus statement National Institutes of Health 1994 

  6. Caritis, Steve N., Toig, Gary, Heddinger, Lynn A., Ashmead, Graham. A double-blind study comparing ritodrine and terbutaline in the treatment of preterm labor. American journal of obstetrics and gynecology, vol.150, no.1, 7-14.

  7. Kosasa, Thomas S., Nakayama, Roy T., Hale, Ralph W., Rinzler, Gary S., Freitas, Cora A.. RITODRINE AND TERBUTALINE COMPARED FOR THE TREATMENT OF PRETERM LABOR. Acta obstetricia et gynecologica Scandinavica : AOGS, vol.64, no.5, 421-426.

  8. Beall, Marie H., Edgar, Bruce W., Paul, Richard H., Smith-Wallace, Toni. A comparison of ritodrine, terbutaline, and magnesium sulfate for the suppression of preterm labor. American journal of obstetrics and gynecology, vol.153, no.8, 854-859.

  9. J Reprod Med Miller JM 348 27 1982 A comparison of magnesium sulfate and terbutaline for the arrest of premature labor: a preliminary report 

  10. Obstet Gynecol Chau AC 847 80 1992 A prospective comparison of terbutaline and magnesium for tocolysis 

  11. Zuckerman, Henryk, Shalev, Eliezer, Gilad, Gabriel, Katzuni, Eliahu. Further study of the inhibition of premature labor by indomethacin. Part I. Journal of perinatal medicine, vol.12, no.1, 19-24.

  12. Ulmsten, U., Andersson, K. -E., Wingerup, L.. Treatment of premature labor with the calcium antagonist nifedipine. Archives of gynecology, vol.229, no.1, 1-5.

  13. Ulmsten, U.. Treatment of normotensive and hypertensive patients with preterm labor using oral nifedipine, a calcium antagonist. Archives of gynecology, vol.236, no.2, 69-72.

  14. READ, M. D., WELLBY, D. E.. The use of a calcium antagonist (nifedipine) to suppress preterm labour. British journal of obstetrics and gynaecology, vol.93, no.9, 933-937.

  15. KING, JAMES F., GRANT, ADRIAN, KEIRSE, MARC J. N. C., CHALMERS, IAIN. Beta‐mimetics in preterm labour: an overview of the randomized controlled trials. British journal of obstetrics and gynaecology, vol.95, no.3, 211-222.

  16. J Reprod Med Cotton DB 92 29 1984 Comparison of magnesium sulfate, terbutaline and a placebo for inhibition of preterm labor: a randomized study 

  17. Obstet Gynecol Morales WJ 567 74 1989 Efficacy and safety of indomethacin versus ritodrine in the management of preterm labour: a randomized study 

  18. Morales, Walter J., Madhav, Harrish. Efficacy and safety of indomethacin compared with magnesium sulfate in the management of preterm labor: A randomized study. American journal of obstetrics and gynecology, vol.169, no.1, 97-102.

  19. Papatsonis, D.N.M., Van Geijn, H.P., Adèr, H.J., Lange, F.M., Bleker, O.P., Dekker, G.A.. Nifedipine and ritodrine in the management of preterm labor: A randomized multicenter trial. Obstetrics and gynecology, vol.90, no.2, 230-234.

  20. Rosen, L.J., Zucker, D., Oppenheimer-Gazit, V., Yagel, S.. The great tocolytic debate: Some pitfalls in the study of safety. American journal of obstetrics and gynecology, vol.184, no.2, 1-7.

  21. Husslein, Peter, Fuchs, Anna-Riitta, Fuchs, Fritz. Oxytocin and the initiation of human parturition***. American journal of obstetrics and gynecology, vol.141, no.5, 688-693.

  22. Fuchs, Anna-Riitta, Romero, Roberto, Keefe, David, Parra, Manuel, Oyarzun, Enrique, Behnke, Ernesto. Oxytocin secretion and human parturition: Pulse frequency and duration increase during spontaneous labor in women. American journal of obstetrics and gynecology, vol.165, no.4, 1515-1523.

  23. Goodwin, T.Murphy, Paul, Richard, Silver, Helayne, Spellacy, William, Parsons, Michael, Chez, Ronald, Hayashi, Robert, Valenzuela, Guillermo, Creasy, George W., Merriman, Rosanne. The effect of the oxytocin antagonist atosiban on preterm uterine activity in the human. American journal of obstetrics and gynecology, vol.170, no.2, 474-478.

  24. Goodwin, T M, Valenzuela, G, Silver, H, Hayashi, R, Creasy, G W, Lane, R. Treatment of preterm labor with the oxytocin antagonist atosiban.. American journal of perinatology, vol.13, no.3, 143-146.

  25. tan, New Jersey, Detroit, Michigan, Memphis, Tennessee, Jacksonville, Florida, San Bernardino and Los Angeles, California, Winston-Salem, North Carolina, Fort Worth, Texas, Jackson, Mississippi, Salt Lake City, Utah, and Raritan, New Jersey, Detroit, Michigan, Memphis, Tennessee, Jacksonville, Florida, San Bernardino and Los Angeles, California, Winston-Salem, North Carolina, Fort Worth, Texas, Jackson, Mississippi, Salt Lake City, Utah, and Raritan, New Jersey, Detroit, Michigan, Memphis, Tennessee, Jacksonville, Florida, San Bernardino and Los Angeles, California, Winston-Salem, North Carolina, Fort Worth, Texas, Jackson, Mississippi, Salt Lake City, Utah, and Raritan, New Jersey, Detroit, Michigan, Memphis, Tennessee, Jacksonville, Florida, San Bernardino and Los Angeles, California, Winston-Salem, North Carolina, Fort Worth, Texas, Jackson, Mississippi, Salt Lake City, Utah, and Raritan, New Jersey. An oxytocin receptor antagonist (atosiban) in the treatment of preterm labor: A randomized, double-blind, placebo-controlled trial with tocolytic rescue. American journal of obstetrics and gynecology, vol.182, no.5, 1173-1183.

  26. 10.1111/j.1471-0528.2001.00043.x 

  27. Treatment of preterm labor with the oxytocin antagonist atosiban: a double-blind, randomized, controlled comparison with salbutamol. European journal of obstetrics, gynecology and reproductive biology, vol.98, no.2, 177-185.

  28. 10.1034/j.1600-0412.2001.d01-456.x 

  29. Ontario, Halifax, Nova Scotia, and Vancouver, British Columbia, Canada, and Beer Yakov, Jerusalem, Kfar Saba, Beer-Sheva, Afula, Haifa, and Tel-Hashomer, Israel, Sherbrooke and Montreal, Quebec, Toronto and Hamilton, Ontario, Halifax, Nova Scotia, and Vancouver, British Columbia, Canada, and Beer Yakov, Jerusalem, Kfar Saba, Beer-Sheva, Afula, Haifa, and Tel-Hashomer, Israel, Sherbrooke and Montreal, Quebec, Toronto and Hamilton, Ontario, Halifax, Nova Scotia, and Vancouver, British Columbia, Canada, and Beer Yakov, Jerusalem, Kfar Saba, Beer-Sheva, Afula, Haifa, and Tel-Hashomer, Israel, Sherbrooke and Montreal, Quebec, Toronto and Hamilton, Ontario, Halifax, Nova Scotia, and Vancouver, British Columbia, Canada, and Beer Yakov, Jerusalem, Kfar Saba, Beer-Sheva, Afula, Haifa, and Tel-Hashomer, Israel, Sherbrooke and Montreal, Quebec, Toronto and Hamilton, Ontario, Halifax, Nova Scotia, and Vancouver, British Columbia, Canada, and Beer Yakov, Jerusalem, Kfar Saba, Beer-Sheva, Afula. Double-blind, randomized, controlled trial of atosiban and ritodrine in the treatment of preterm labor: A multicenter effectiveness and safety study. American journal of obstetrics and gynecology, vol.182, no.5, 1191-1199.

  30. , Colorado, Oklahoma City, Oklahoma, and Raritan, New Jersey, Colton and San Diego, California, Jacksonville, Florida, Detroit, Michigan, Providence, Rhode Island, Honolulu, Hawaii, Denver, Colorado, Oklahoma City, Oklahoma, and Raritan, New Jersey. Maintenance treatment of preterm labor with the oxytocin antagonist atosiban. American journal of obstetrics and gynecology, vol.182, no.5, 1184-1190.

  31. Sorensen, H. T., Sabroe, S., Olsen, J., Rothman, K. J, Gillman, M. W, Fischer, P.. Birth weight and cognitive function in young adult life: historical cohort study. BMJ : British medical journal, vol.315, no.7105, 401-403.

  32. Helmer, H., Brunbauer, M., Schatten, C., Rohrmeister, K., Husslein, P.. Treatment with the Oxytocin Receptor Antagonist Atosiban in Patients with Risk of Pre-term Delivery. Geburtshilfe und Frauenheilkunde : Ergebnisse der Forschung für die Praxis, vol.61, no.10, 755-760.

섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로